You’re using a public version of DrugChatter with 1 free searches available. Register to unlock more free searches per day. CREATE FREE ACCOUNT

Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Latanoprost formulation?



Latanoprost is a medication used to treat high pressure inside the eye, a condition known as intraocular pressure (IOP), which can lead to glaucoma. It belongs to a class of drugs called prostaglandin analogs, which work by increasing the outflow of fluid from the eye, thereby reducing IOP [3].

The formulation of latanoprost can vary depending on the manufacturer. One of the available formulations is a sterile ophthalmic solution, which is administered as eye drops. The solution contains latanoprost as the active ingredient, along with other ingredients such as benzalkonium chloride, sodium chloride, and water for injection [2].

The ophthalmic solution is typically supplied in a plastic bottle with a dropper tip for easy application. The recommended dose is usually one drop in the affected eye(s) once daily, preferably in the evening [2].

It is important to note that the specific formulation and dosing instructions may vary depending on the brand and country. Therefore, it is essential to consult the prescribing information or package insert provided by the manufacturer or refer to the guidance of a healthcare professional for accurate and up-to-date information regarding the specific formulation of latanoprost [2].

In conclusion, latanoprost is available as a sterile ophthalmic solution administered as eye drops. It is used to treat high pressure inside the eye and is typically dosed once daily. The formulation and dosing instructions may vary depending on the manufacturer and country, so it is important to refer to the prescribing information or consult a healthcare professional for accurate and specific information [2][3].

Sources:
[2] FDA Prescribing Information for Latanoprost: https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020597s044lbl.pdf
[3] National Center for Biotechnology Information (NCBI) - Latanoprost: https://www.ncbi.nlm.nih.gov/books/NBK540978/



Follow-up:   How does the latanoprost formulation differ from other medications? Are there any side effects associated with the latanoprost formulation? Can the latanoprost formulation be used for other eye conditions?





DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2024. All rights reserved.